2021
The impact and collateral damage of COVID-19 on prostate MRI and guided biopsy operations: Society of Abdominal Radiology Prostate Cancer Disease-Focused Panel survey analysis
Surasi DSS, Wang X, Bathala TK, Hwang H, Arora S, Westphalen AC, Chang SD, Turkbey B. The impact and collateral damage of COVID-19 on prostate MRI and guided biopsy operations: Society of Abdominal Radiology Prostate Cancer Disease-Focused Panel survey analysis. Abdominal Radiology 2021, 46: 4362-4369. PMID: 33904992, PMCID: PMC8077193, DOI: 10.1007/s00261-021-03087-8.Peer-Reviewed Original ResearchConceptsBowel preparationMedian numberProstate MRICoronavirus disease 2019 (COVID-19) pandemicCOVID-19Disease 2019 pandemicCOVID-19 pandemicHealth care systemComplete responseMedical oncologyProstate biopsyClinic schedulesProstate cancerMRI studiesLockdown periodCare systemCollateral damageRadiation oncologyClinical departmentsPanel survey analysisMRIBiopsyRadiology departmentOncologyDescriptive statistics
2016
Magnetic resonance-ultrasound fusion prostate biopsy in the diagnosis of prostate cancer
Tyson MD, Arora SS, Scarpato KR, Barocas D. Magnetic resonance-ultrasound fusion prostate biopsy in the diagnosis of prostate cancer. Urologic Oncology Seminars And Original Investigations 2016, 34: 326-332. PMID: 27083114, PMCID: PMC4912896, DOI: 10.1016/j.urolonc.2016.03.005.Peer-Reviewed Original ResearchConceptsMultiparametric magnetic resonance imagingMR-US fusionProstate cancerMR-US fusion biopsyLow-risk cancersFusion prostate biopsyProstate needle biopsyBore MRI-guided biopsyMRI-guided biopsyMagnetic resonance imagingInsignificant diseaseFusion biopsyProstate biopsyNeedle biopsySuspicious lesionsTransrectal ultrasoundBiopsyBiopsy techniqueResonance imagingCancerDirect targetingRelevant diseasesProstateDiseaseDiagnosis